Detalles de la búsqueda
1.
ALTA-2: Phase II study of brigatinib in patients with ALK-positive, advanced non-small-cell lung cancer who progressed on alectinib or ceritinib.
Future Oncol
; 17(14): 1709-1719, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33569983
2.
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(3): 408-419, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30738780
3.
Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload.
Blood
; 125(25): 3868-77, 2015 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25934475
4.
Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine.
Am J Hematol
; 90(2): 91-6, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25345697
5.
Overall survival indirect treatment comparison between brigatinib and alectinib for the treatment of front-line anaplastic lymphoma kinase-positive non-small cell lung cancer using data from ALEX and final results from ALTA-1L.
Curr Med Res Opin
; 38(9): 1587-1593, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35815801
6.
Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette.
Nicotine Tob Res
; 12(8): 855-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20584771
7.
Mapping and characterization of vicriviroc resistance mutations from HIV-1 isolated from treatment-experienced subjects enrolled in a phase II study (VICTOR-E1).
J Acquir Immune Defic Syndr
; 56(3): 222-9, 2011 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21209592
Resultados
1 -
7
de 7
1
Próxima >
>>